missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. Somatostatin R2/SSTR2 Antibody (SSTR2/7532), Novus Biologicals™
  7. 18624084

Somatostatin R2/SSTR2 Antibody (SSTR2/7532), Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP3-20646-100ug

 View more versions of this product

Product Code. 18624084

  • € 494.00 / 100µg

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

Somatostatin R2/SSTR2 Monoclonal antibody specifically detects Somatostatin R2/SSTR2 in Human samples. It is validated for Immunohistochemistry (Paraffin)
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Somatostatin R2/SSTR2
Monoclonal
0.2 mg/ml
Immunohistochemistry-Paraffin 1-2 μg/mL
somatostatin receptor 2, somatostatin receptor type 2, SRIF-1, SS2R, SS-2-R, SS2-R
Recombinant fragment (around aa 169-369) of human Somatostatin R2/SSTR2 (exact sequence is proprietary)
100 μg
Alzheimers Research, Cancer, Cell Cycle and Replication, GPCR, Neuronal Cell Markers, Neuroscience, Neurotransmission
6752
Store at 4&drg;C. Do not freeze.
IgG2b λ
Immunohistochemistry (Paraffin)
SSTR2/7532
Unconjugated
10mM PBS with 0.05% BSA
Mouse
Protein A or G purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.